301 related articles for article (PubMed ID: 27287890)
1. Tumoral gene silencing by receptor-targeted combinatorial siRNA polyplexes.
Lee DJ; He D; Kessel E; Padari K; Kempter S; Lächelt U; Rädler JO; Pooga M; Wagner E
J Control Release; 2016 Dec; 244(Pt B):280-291. PubMed ID: 27287890
[TBL] [Abstract][Full Text] [Related]
2. Dual antitumoral potency of EG5 siRNA nanoplexes armed with cytotoxic bifunctional glutamyl-methotrexate targeting ligand.
Lee DJ; Kessel E; Edinger D; He D; Klein PM; Voith von Voithenberg L; Lamb DC; Lächelt U; Lehto T; Wagner E
Biomaterials; 2016 Jan; 77():98-110. PubMed ID: 26584350
[TBL] [Abstract][Full Text] [Related]
3. Systemic Delivery of Folate-PEG siRNA Lipopolyplexes with Enhanced Intracellular Stability for In Vivo Gene Silencing in Leukemia.
Lee DJ; Kessel E; Lehto T; Liu X; Yoshinaga N; Padari K; Chen YC; Kempter S; Uchida S; Rädler JO; Pooga M; Sheu MT; Kataoka K; Wagner E
Bioconjug Chem; 2017 Sep; 28(9):2393-2409. PubMed ID: 28772071
[TBL] [Abstract][Full Text] [Related]
4. Combinatorial siRNA Polyplexes for Receptor Targeting.
Lee DJ; Wagner E
Methods Mol Biol; 2019; 1974():83-98. PubMed ID: 31098997
[TBL] [Abstract][Full Text] [Related]
5. Folate receptor-directed orthogonal click-functionalization of siRNA lipopolyplexes for tumor cell killing in vivo.
Klein PM; Kern S; Lee DJ; Schmaus J; Höhn M; Gorges J; Kazmaier U; Wagner E
Biomaterials; 2018 Sep; 178():630-642. PubMed ID: 29580727
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationships of siRNA carriers based on sequence-defined oligo (ethane amino) amides.
Fröhlich T; Edinger D; Kläger R; Troiber C; Salcher E; Badgujar N; Martin I; Schaffert D; Cengizeroglu A; Hadwiger P; Vornlocher HP; Wagner E
J Control Release; 2012 Jun; 160(3):532-41. PubMed ID: 22465674
[TBL] [Abstract][Full Text] [Related]
7. Post-PEGylation of siRNA Lipo-oligoamino Amide Polyplexes Using Tetra-glutamylated Folic Acid as Ligand for Receptor-Targeted Delivery.
Müller K; Kessel E; Klein PM; Höhn M; Wagner E
Mol Pharm; 2016 Jul; 13(7):2332-45. PubMed ID: 27177200
[TBL] [Abstract][Full Text] [Related]
8. Targeted decationized polyplexes for siRNA delivery.
Novo L; Takeda KM; Petteta T; Dakwar GR; van den Dikkenberg JB; Remaut K; Braeckmans K; van Nostrum CF; Mastrobattista E; Hennink WE
Mol Pharm; 2015 Jan; 12(1):150-61. PubMed ID: 25384057
[TBL] [Abstract][Full Text] [Related]
9. Combinatorial optimization of PEG architecture and hydrophobic content improves ternary siRNA polyplex stability, pharmacokinetics, and potency in vivo.
Werfel TA; Jackson MA; Kavanaugh TE; Kirkbride KC; Miteva M; Giorgio TD; Duvall C
J Control Release; 2017 Jun; 255():12-26. PubMed ID: 28366646
[TBL] [Abstract][Full Text] [Related]
10. Efficient and Tumor Targeted siRNA Delivery by Polyethylenimine-graft-polycaprolactone-block-poly(ethylene glycol)-folate (PEI-PCL-PEG-Fol).
Liu L; Zheng M; Librizzi D; Renette T; Merkel OM; Kissel T
Mol Pharm; 2016 Jan; 13(1):134-43. PubMed ID: 26641134
[TBL] [Abstract][Full Text] [Related]
11. Co-delivery of pretubulysin and siEG5 to EGFR overexpressing carcinoma cells.
Truebenbach I; Zhang W; Wang Y; Kern S; Höhn M; Reinhard S; Gorges J; Kazmaier U; Wagner E
Int J Pharm; 2019 Oct; 569():118570. PubMed ID: 31352048
[TBL] [Abstract][Full Text] [Related]
12. Hydrophobic interactions between polymeric carrier and palmitic acid-conjugated siRNA improve PEGylated polyplex stability and enhance in vivo pharmacokinetics and tumor gene silencing.
Sarett SM; Werfel TA; Chandra I; Jackson MA; Kavanaugh TE; Hattaway ME; Giorgio TD; Duvall CL
Biomaterials; 2016 Aug; 97():122-32. PubMed ID: 27163624
[TBL] [Abstract][Full Text] [Related]
13. Nanosized multifunctional polyplexes for receptor-mediated siRNA delivery.
Dohmen C; Edinger D; Fröhlich T; Schreiner L; Lächelt U; Troiber C; Rädler J; Hadwiger P; Vornlocher HP; Wagner E
ACS Nano; 2012 Jun; 6(6):5198-208. PubMed ID: 22646997
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor targeted methotrexate and small interfering RNA co-delivery.
Steinborn B; Truebenbach I; Morys S; Lächelt U; Wagner E; Zhang W
J Gene Med; 2018 Jul; 20(7-8):e3041. PubMed ID: 29949222
[TBL] [Abstract][Full Text] [Related]
15. PEGylated carboxymethyl chitosan/calcium phosphate hybrid anionic nanoparticles mediated hTERT siRNA delivery for anticancer therapy.
Xie Y; Qiao H; Su Z; Chen M; Ping Q; Sun M
Biomaterials; 2014 Sep; 35(27):7978-91. PubMed ID: 24939077
[TBL] [Abstract][Full Text] [Related]
16. Gene silencing and antitumoral effects of Eg5 or Ran siRNA oligoaminoamide polyplexes.
Edinger D; Kläger R; Troiber C; Dohmen C; Wagner E
Drug Deliv Transl Res; 2014 Feb; 4(1):84-95. PubMed ID: 25786619
[TBL] [Abstract][Full Text] [Related]
17. Conjugate Polyplexes with Anti-Invasive Properties and Improved siRNA Delivery In Vivo.
Chen Y; Li J; Oupický D
Bioconjug Chem; 2018 Feb; 29(2):296-305. PubMed ID: 29338191
[TBL] [Abstract][Full Text] [Related]
18. Silencing of GFP expression in human mesenchymal stem cells using quaternary polyplexes of siRNA-PEI with glycosaminoglycans and albumin.
Herrera LC; Shastri VP
Acta Biomater; 2019 Nov; 99():397-411. PubMed ID: 31541736
[TBL] [Abstract][Full Text] [Related]
19. Dual-responsive polyplexes with enhanced disassembly and endosomal escape for efficient delivery of siRNA.
Zhu J; Qiao M; Wang Q; Ye Y; Ba S; Ma J; Hu H; Zhao X; Chen D
Biomaterials; 2018 Apr; 162():47-59. PubMed ID: 29432988
[TBL] [Abstract][Full Text] [Related]
20. Stabilization of polyplexes via polymer crosslinking for efficient siRNA delivery.
Fröhlich T; Edinger D; Russ V; Wagner E
Eur J Pharm Sci; 2012 Dec; 47(5):914-20. PubMed ID: 23000380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]